You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Litigation Details for In Re Copaxone 40 MG Consolidated Cases (D. Del. 2014)

✉ Email this page to a colleague

« Back to Dashboard

In Re Copaxone 40 MG Consolidated Cases (D. Del. 2014)

Docket	⤷ Sign Up	Date Filed	2014-09-10
Court	District Court, D. Delaware	Date Terminated	2017-01-31
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	Defendant	Referred To
Parties	PFIZER INC.
Patents	6,054,430; 6,342,476; 6,362,161; 6,468,967; 6,852,689; 7,199,098; 8,232,250; 8,399,413; 8,552,025; 8,969,302; 9,155,776
Attorneys	Carolyn A. Alenci
Firms	JPMorgan Chase & Co.
Link to Docket	External link to docket

Small Molecule Drugs cited in In Re Copaxone 40 MG Consolidated Cases

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for In Re Copaxone 40 MG Consolidated Cases (D. Del. 2014)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2015-11-03	114	Stipulation	invalidity of U.S. Patent Nos. 8,232,250 (“the ’250 patent”), 8,399,413 (“the ’413 patent”), and 8,969,302…8,969,302 (“the ’302 patent) (collectively, the “patents-in-suit”), which, like the ’776 patent, are …’776 patent shares a common inventor and specification with the patents-in-suit and each patent is generally… Court: WHEREAS, U.S. Patent No. 9,155,776 (“the ’776 patent”) issued on October 13, 2015 and…that the patents involve similar subject matter, amending the pleadings to include the ’776 patent would	External link to document
2015-11-10	116	Patent/Trademark Report to Commissioner	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,232,250; 8,399,413; 8,969,302…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. Delaware	External link to document
2015-11-20	127	Notice of Service	Defendants' Proposed Claim Constructions for U.S. Patent No. 9,155,776 filed by Mylan Inc., Mylan Pharmaceuticals…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. Delaware	External link to document
2015-12-04	130	Notice of Service	Joint Invalidity Contentions Regarding U.S. Patent No. 9,155,776 B2 filed by Momenta Pharmaceuticals Inc.…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. Delaware	External link to document
2015-12-18	139	Claim Construction Opening Brief	CONSTRUCTION OPENING BRIEF Regarding U.S. Patent No. 9,155,776 filed by Momenta Pharmaceuticals Inc., Sandoz…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.